UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory scrutiny. Experts point to its aggressive Medicare Advantage strategy and a rapidly evolving healthcare landscape as key drivers of its challenges. The post Analysis: The No Good, Very Bad Year for UnitedHealth appeared first on MedCity News.
Numerous insurers — including Oscar Health, Elevance Health, Molina Healthcare and Centene — have announced they’re cutting or withdrawing their earnings guidance for the year. And the individual market seems to be the culprit. The post Why Several Insurers Are Cutting/Withdrawing Their Earnings Guidance appeared first on MedCity News.
Each year, the Indian Health Service rejects tens of thousands of requests to fund outside care that it doesn’t provide, forcing patients to go without treatment or pay big medical bills themselves. The IHS is supposed to provide free care to Native Americans, but it does so only at scattered clinics and hospitals the agency funds and then manages…
It’s about interpreting the full range of factors, from biology to life circumstances, that can push someone to the edge. The post A New Perspective on Suicide: It’s More Than Just Depression appeared first on MedCity News.
Roivant Sciences subsidiary Pulmovant is on track for a Phase 2 test of mosliciguat as a treatment for pulmonary hypertension associated with interstitial lung disease. The inhaled drug offers a different mechanism of action and less burdensome dosing compared to United Therapeutics’ blockbuster PH-ILD drug, Tyvaso. The post Bayer Asset Gives Roivant Sciences’ New ‘Vant’…
UCSF researcher Maria Shcherbakova highlighted how adaptive deep brain stimulation is improving Parkinson’s care by automatically adjusting brain implants in real time to better control symptoms. The post How Medtronic & UCSF Are Giving Parkinson’s Patients Greater Control Over Their Symptoms appeared first on MedCity News.
Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat metastatic melanoma and lung cancer. Ads for Skyrizi, a medicine to treat plaque psoriasis and other illnesses, show patients snorkeling and riding bikes — flashing their rash-free elbows. People with Type…
By GEORGE BEAUREGARD During my years in a bustling metropolitan primary care practice from 1992 to 2010, I recall only a handful of patients under 50 who developed cancer. Not surprisingly, these were mostly cases of Hodgkin’s and Non-Hodgkin’s lymphomas, myeloma, skin, and breast cancer. Fortunately, those few patients were wearing the mantle of cancer…
“Democrats are threatening to shut down the entire government because they want to give hundreds of billions of dollars of health care benefits to illegal aliens.” Vice President JD Vance in a Sept. 28, 2025, Fox News interview As the U.S. headed for a government shutdown, Republicans repeatedly accused Democrats of forcing the closure because…
Dan Liljenquist, Intermountain Health’s chief strategy officer, said that more large health systems should employ a hub-and-spoke model to ensure that rural providers can thrive. Under this model, large health systems partner with rural hospitals — with the rural “spoke” hospitals gaining access to the larger “hub” health system’s technology, staff, medication discounts and more….